Next Article in Journal
Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses
Next Article in Special Issue
The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
Previous Article in Journal
Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
Previous Article in Special Issue
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
 
 
Article

Article Versions Notes

Cancers 2018, 10(6), 169; https://doi.org/10.3390/cancers10060169
Action Date Notes Link
article xml file uploaded 30 May 2018 12:02 CEST Original file -
article xml uploaded. 30 May 2018 12:02 CEST Update https://www.mdpi.com/2072-6694/10/6/169/xml
article pdf uploaded. 30 May 2018 12:02 CEST Version of Record https://www.mdpi.com/2072-6694/10/6/169/pdf
article supplementary file uploaded. 30 May 2018 12:02 CEST - https://www.mdpi.com/2072-6694/10/6/169#supplementary
article html file updated 30 May 2018 18:44 CEST Original file -
article html file updated 25 June 2018 11:52 CEST Update -
article html file updated 30 March 2019 05:54 CET Update -
article html file updated 16 April 2019 15:57 CEST Update -
article html file updated 30 April 2019 15:26 CEST Update -
article html file updated 4 October 2019 02:23 CEST Update -
article html file updated 9 February 2020 19:34 CET Update https://www.mdpi.com/2072-6694/10/6/169/html
Back to TopTop